Literature DB >> 3857369

Estrogen and sex hormone-binding globulin levels in nulliparous and parous women.

L Bernstein, M C Pike, R K Ross, H L Judd, J B Brown, B E Henderson.   

Abstract

The hormone profiles of nulliparous and parous women on day 11 of their menstrual cycle have been studied in an attempt to seek evidence for the hormonal basis of the protective effect of first birth on breast cancer risk. A previous publication reported that there were significantly lower (26%) early morning prolactin levels in parous women as compared to those levels in nulliparous women but that there were no differences in plasma and urinary estrogen levels. The present study shows, however, that parous women had significantly shorter cycle lengths than nulliparous women of the same age, and the data were reevaluated with this difference being taken into account. After adjustment for cycle length (within the range of 24-32 days) and age, estrogen levels were significantly lower (22%) in parous women compared to those in nulliparous women. Two further aspects of estrogen metabolism were measured in the plasma samples of these women: the binding capacity of sex hormone-binding globulin (SHBG) and the percentage of free estradiol (E2). SHBG levels were 12% higher in parous women, but there was no difference in percentage of free E2. In the previous publication it was suggested that the protective effect of first birth on breast cancer risk was mediated in part by permanently lowering prolactin levels. The current findings suggest that changes in estrogen metabolism also are a factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857369

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  68 in total

1.  Differences in ovarian hormones in relation to parity and time since last birth.

Authors:  Emily S Barrett; Lauren E Parlett; Gayle C Windham; Shanna H Swan
Journal:  Fertil Steril       Date:  2014-03-28       Impact factor: 7.329

Review 2.  The international variation in breast cancer rates: an epidemiological assessment.

Authors:  B E Henderson; L Bernstein
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

3.  Age at menarche and estrogen concentrations of adult women.

Authors:  L Bernstein; M C Pike; R K Ross; B E Henderson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

Review 4.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

5.  Parity is associated with increased waist circumference and other anthropometric indices of obesity.

Authors:  A A Mansour; N A H Ajeel
Journal:  Eat Weight Disord       Date:  2009 Jun-Sep       Impact factor: 4.652

Review 6.  Links between alcohol consumption and breast cancer: a look at the evidence.

Authors:  Ying Liu; Nhi Nguyen; Graham A Colditz
Journal:  Womens Health (Lond)       Date:  2015-01

Review 7.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

8.  Parity and risk of ovarian cysts: Cross-sectional evidence from the Dongfeng-Tongji cohort study.

Authors:  Chrispin Mandiwa; Li-Jun Shen; Yao-Hua Tian; Lu-Lu Song; Gui-Qiang Xu; Si-Yi Yang; Yuan Liang; Jing Yuan; You-Jie Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

9.  Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study.

Authors:  Alexandra Wexler; Trond Sand; Tor B Elsås
Journal:  BMC Ophthalmol       Date:  2010-05-13       Impact factor: 2.209

10.  Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Authors:  Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2010-06-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.